EBR Systems, Inc. (ASX:EBR)
Australia · Delayed Price · Currency is AUD 1.370
+0.020 (1.48%)
Jul 22, 2025, 4:10 PM AEST
EBR Systems Company Description
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation.
The company offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of wires or leads; and SOLVE-CRT, an investigational device exemption.
The company was incorporated in 2003 and is headquartered in Sunnyvale, California.
EBR Systems, Inc.
| Country | United States |
| Founded | 2003 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 89 |
| CEO | John McCutcheon |
Contact Details
Address: 480 Oakmead Parkway Sunnyvale, Delaware 94085 United States | |
| Phone | 408 720 1906 |
| Website | ebrsystemsinc.com |
Stock Details
| Ticker Symbol | EBR |
| Exchange | Australian Securities Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | AU0000182552 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| John Graham McCutcheon B.A., M.B.A. | President, Chief Executive Officer and Director |
| Allan Roger Will B.S., M.S. | Executive Chairman |
| Gary W. Doherty B.S. | Chief Financial Officer |
| Michael Hendricksen B.S., M.S. | Chief Operating Officer |
| Dr. N. Parker Willis B.S., M.S., Ph.D. | Chief Technology Officer |
| Andrew Shute B.S. | Chief Corporate Development Officer |
| Dr. Spencer H. Kubo M.D. | Chief Medical Officer |
| Erik Strandberg | Chief Commercial Officer |
| Pharoah Garma | Chief Regulatory Officer |
| John H. Sellers | Secretary |